"Bulletin","Class_of_antibiotics","Antibiotic","Isolated","Resistance","95_IC_low","95_IC_upper"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Penicilline","Penicillina",930,"2.8","1.8","4.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Cefalosporine III generazione","Ceftriaxone",806,"0.4","0.1","1.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Cefalosporine III generazione","Cefotaxime",923,"0.4","0.1","1.1"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Macrolidi","Eritromicina",1099,"20.3","17.9","22.8"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Tetracicline","Tetraciclina",800,"17.2","14.7","20.0"
"https://github.com/fbranda/amr/blob/main/bulletins/Italy/AR-ISS/AMR_AR_ISS_2018.pdf","Sulfamidici","Cotrimossazolo",348,"7.2","4.7","10.4"
